If you are taking Xanax and Wegovy together, or are considering this combination, certain situations require prompt medical attention or review by your healthcare provider
Food and Drug Administration (FDA) as a way to reduce the risk of major adverse cardiovascular events in patients who are overweight or obese and present with cardiovascular disease (CVD)
0.3%), but none in either group were severe.[1] Injection site reactions are usually manageable, are not true side effects, and do not necessarily lead to having to stop the medication
Clients value learning how open communication supports better program experiences
FDA has issued a box warning of the risk of thyroid cancers and are contraindicated liraglutide, exenatide (once weekly), and semaglutide (both oral and injectable) in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia types 2 A or 2B [135, 136]